Total Payments
$2,815
2024 Payments
$2,196
Companies
36
Transactions
122
Medicare Patients
1,159
Medicare Billing
$119,470
Payment Breakdown by Category
Food & Beverage$2,762 (98.1%)
Education$53.21 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,762 | 121 | 98.1% |
| Education | $53.21 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $618.61 | 19 | $0 (2024) |
| Amgen Inc. | $261.75 | 9 | $0 (2024) |
| Novo Nordisk Inc | $256.39 | 14 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $195.51 | 7 | $0 (2023) |
| PFIZER INC. | $132.51 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $102.55 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $89.38 | 1 | $0 (2024) |
| ABBVIE INC. | $86.52 | 4 | $0 (2024) |
| Grifols USA, LLC | $86.26 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $85.31 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,196 | 93 | AstraZeneca Pharmaceuticals LP ($555.12) |
| 2023 | $558.76 | 24 | Regeneron Healthcare Solutions, Inc. ($195.51) |
| 2022 | $25.20 | 2 | Currax Pharmaceuticals LLC ($13.51) |
| 2021 | $34.54 | 3 | Novo Nordisk Inc ($23.48) |
All Payment Transactions
122 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: Narcoplepsy | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Neuropsychiatry | ||||||
| 12/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $30.63 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $30.52 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.83 | General |
| Category: Cardiovascular | ||||||
| 11/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.17 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.14 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: CNS | ||||||
| 10/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $94.54 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.01 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 09/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: VACCINES | ||||||
| 09/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 512 | 811 | $339,468 | $49,523 |
| 2022 | 7 | 368 | 541 | $134,822 | $35,497 |
| 2021 | 7 | 188 | 393 | $60,497 | $20,676 |
| 2020 | 4 | 91 | 347 | $35,592 | $13,773 |
Total Patients
1,159
Total Services
2,092
Medicare Billing
$119,470
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 229 | 448 | $247,848 | $35,294 | 14.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 93 | 93 | $67,518 | $9,913 | 14.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 20 | $5,471 | $1,171 | 21.4% |
| 98980 | Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month | Office | 2023 | 29 | 33 | $7,095 | $1,160 | 16.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 97 | 168 | $3,696 | $688.80 | 18.6% |
| 98981 | Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, each additional 20 minutes per calendar month | Office | 2023 | 16 | 21 | $3,570 | $589.22 | 16.5% |
| 98977 | Device supply with scheduled recording and transmission for remote monitoring of musculoskeletal system, per 30 days | Office | 2023 | 14 | 14 | $3,080 | $509.32 | 16.5% |
| 98975 | Set-up and patient education for remote monitoring of therapy | Office | 2023 | 14 | 14 | $1,190 | $197.26 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 202 | $77,509 | $18,191 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 126 | $24,800 | $7,827 | 31.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 39 | 39 | $18,715 | $5,370 | 28.7% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 39 | 88 | $5,007 | $2,082 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $8,175 | $1,815 | 22.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 39 | 39 | $420.50 | $149.61 | 35.6% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 32 | 32 | $193.92 | $61.92 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 165 | $32,340 | $10,644 | 32.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $8,638 | $2,937 | 34.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2021 | 39 | 101 | $5,635 | $2,454 | 43.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 23 | $6,444 | $2,095 | 32.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 50 | $6,049 | $1,967 | 32.5% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 12 | 12 | $1,131 | $474.98 | 42.0% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 24 | 24 | $260.38 | $104.16 | 40.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 166 | $22,788 | $8,477 | 37.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2020 | 28 | 137 | $6,756 | $3,289 | 48.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 16 | 32 | $3,286 | $1,053 | 32.0% |
About Timothy Lederer
Timothy Lederer is a Family healthcare provider based in Abingdon, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2018. The National Provider Identifier (NPI) number assigned to this provider is 1033695960.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Timothy Lederer has received a total of $2,815 in payments from pharmaceutical and medical device companies, with $2,196 received in 2024. These payments were reported across 122 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($2,762).
As a Medicare-enrolled provider, Lederer has provided services to 1,159 Medicare beneficiaries, totaling 2,092 services with total Medicare billing of $119,470. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Abingdon, MD
- Active Since 07/13/2018
- Last Updated 11/21/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1033695960
Products in Payments
- FARXIGA (Drug) $245.64
- DUPIXENT (Biological) $236.57
- BREZTRI (Drug) $195.95
- Ozempic (Drug) $155.14
- Otezla (Drug) $142.82
- FASENRA (Biological) $108.58
- Repatha (Biological) $95.76
- ELIQUIS (Drug) $91.51
- Veozah (Drug) $89.38
- Prolastin-C Liquid (Biological) $86.26
- REXULTI (Drug) $76.73
- AIRSUPRA (Drug) $68.44
- SPRAVATO (Drug) $67.74
- QULIPTA (Drug) $61.33
- MOUNJARO (Drug) $57.89
- XOLAIR (Drug) $56.71
- Zemaira (Drug) $54.20
- TRELEGY ELLIPTA (Drug) $51.51
- PREVNAR 20 (Biological) $51.02
- Kerendia (Drug) $48.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Abingdon
Mrs. Lora Reynolds, Fnp, FNP
Family — Payments: $40,459
Family $40,459
Ms. Eleanor Hess, Fnp, FNP
Family — Payments: $9,086
Family $9,086
Amy Almany, Fnp, FNP
Family — Payments: $8,234
Family $8,234
Makayla White, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $6,107
Family $6,107
Ms. Catrina Ratliff, Fnp, FNP
Family — Payments: $5,140
Family $5,140
Victoria Whitt, Fnp, FNP
Family — Payments: $4,482
Family $4,482